Rescue therapy with methylene blue in systemic inflammatory response syndrome after cardiac surgery

Canadian Journal of Cardiology

Volumn 19, Issue 2, 2003, Pages 167-169

  Dagenais, François ^a   Mathieu, Patrick ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Methylene blue; Vasoplegia

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOPAMINE; METHYLENE BLUE; NORADRENALIN; VASOPRESSIN;

ACUTE KIDNEY FAILURE; AGED; ANNULOPLASTY; ARTICLE; CARDIOPULMONARY BYPASS; CASE REPORT; CORONARY ARTERY BYPASS GRAFT; DRUG MEGADOSE; DYSPNEA; HEART EJECTION FRACTION; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEMOFILTRATION; HUMAN; LUNG EDEMA; MALE; MITRAL VALVE PROSTHESIS; MITRAL VALVE REGURGITATION; PERIPHERAL EDEMA; SEPSIS; SINGLE DRUG DOSE; SURGICAL TECHNIQUE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; SYSTEMIC VASCULAR RESISTANCE;

AGED; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; ENZYME INHIBITORS; HEART DISEASES; HUMANS; MALE; METHYLENE BLUE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT OUTCOME;

EID: 0037354599     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Carrel T, Englberger L, Mohacsi P, et al. Low systemic vascular resistance after cardiopulmonary bypass: Incidence, etiology, and clinical importance. J Card Surg 2000;15:347-53.
2. Tuman KJ, McCarthy KJ, O'Connor CJ, et al. Angiotensin-converting enzyme inhibitors increase vasoconstrictor requirements after cardiopulmonary bypass. Anesth Analg 1995;80:473-9.
3. Argenziano M, Chen JM, Choudhri AF, et al. Management of vasodilatory shock after cardiac surgery: Identification of predisposing factors and use of a novel pressor agent. J Thorac Cardiovasc Surg 1998;116:973-80.
4. Gomes WJ, Carvalho AC, Palma JH, et al. Vasoplegic syndrome after open heart surgery. J Cardiovasc Surg 1998;39:619-23.
5. JAMA 100 years ago: Methylene blue in grave malaria cachexia. JAMA 2000;283:2765.
6. Khan NA, Kruse JA. Methemoglobinemia induced by topical anesthesia: A case report and review. Am J Med Sci 1999;318:415-8.
7. Martinez Portillo F, Hoang-Boehm J, Weiss J, et al. Methylene blue as a successful treatment alternative for pharmacologically induced priapism. Eur Urol 2001;39:20-3.
8. Marczin N, Tekeres M, Salzman AL, et al. Methylene blue in septic shock. Crit Care Med 1995;23:259-64.
9. Peer G, Itzhakov E, Wollman Y, et al. Methylene blue, a nitric oxide inhibitor, prevents haemodialysis hypotension. Nephrol Dial Transplant 2001;16:1436-41.
10. Andrade JCS, Batista Filho ML, Evora PRB, et al. Methylene blue administration in the treatment of vasoplegic syndrome after cardiac surgery. Rev Bras Circ Cardiovasc 1996;11:107-14.
11. Yiu P, Robin J, Pattison CW. Reversal of refractory hypotension with single-dose methylene blue after coronary artery bypass procedure. J Thorac Cardiovasc Surg 1999;118:195-6.
12. Parrillo JE. Pathogenic mechanisms of septic shock. N Engl J Med 1993;328:1471-7.
13. Wolkow PP. Involvement and dual affects of nitric oxide in septic shock. Inflamm Res 1998;47:152-66.
14. Hayashi Y, Sawa Y, Nishimura M, et al. P-selectin participates in cardiopulmonary bypass-induced inflammatory response in association with nitric oxide and peroxynitrate production. J Thorac Cardiovasc Surg 2000;120:558-65.
15. Mayers I, Salas E, Hurst T, et al. Increased nitric oxide synthase activity after canine cardiopulmonary bypass is suppressed by s-nitroglutathione. J Thorac Cardiovasc Surg 1999;117:1009-16.
16. Speziale G, Ruvolo G, Marino B. A role for nitric oxide in the vasoplegic syndrome. J Cardiovasc Surg 1996;37:301-3.
17. Myles PS, Leong CK, Currey J. Endogenous nitric oxide and low systemic vascular resistance after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1997;11:571-4.
18. Brett SJ, Quinlan GJ, Mitchell J et al. Production of nitric oxide during surgery involving cardiopulmonary bypass. Crit Care Med 1998;26:272-8.
19. Ohata T, Sawa Y, Kadoba K, et al. Role of nitric oxide in a temperature dependent regulation of systemic vascular resistance in cardiopulmonary bypass. Eur J Cardiothorac Surg 2000;18:342-7.
20. Adamik B, Kubler-Kielb J, Golebiowska B, et al. Effect of sepsis and cardiac surgery with cardiopulmonary bypass on plasma level of nitric oxide metabolites, neopterin, and procalcitonin: Correlation with mortality and postoperative complications. Intensive Care Med 2000;26:1259-67.
21. Gruetter CA, Kadowitz PJ, Ignarro LJ. Methylene blue inhibits coronary arterial relaxation and guanylate cyclase activation by nitroglycerin, sodium nitrate, and amyl nitrate. Can J Physiol Pharmacol 1981;59:150-6.
22. Mayer B, Brunner F, Schmidt K. Novel actions of methylene blue. Eur Heart J 1993;14:22-6.
23. Lomniczi A, Cebral E, Canteros G, et al. Methylene blue inhibits the increase of inducible nitric oxide synthase activity induced by stress and lipopolysaccharide in the medial basal hypothalamus of rats. Neuroimmunomodulation 2000;8:122-7.
24. Kirov MY, Evgenov OV, Evgenov NV, et al. Infusion of methylene blue in human septic shock: A pilot randomized, controlled study. Crit Care Med 2001;29:1860-7.